December 6, 2022
Nature Medicine
University of Texas Medical Branch
Competing interests: X.X. and P.-Y.S. have filed a patent on the reverse genetic system. X.X., J.Z. and P.-Y.S. received compensation from Pfizer for COVID-19 vaccine development. Other authors declare no competing interests.
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law
Copyright © 2022, The Author(s), under exclusive license to Springer Nature America, https://doi.org/10.1038/s41591-022-02162-x
document
COVID-19,mRNA,vaccine systemic and virological concerns,vaccines